TCL Archive In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant October 16, 1998
TCL Archive Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds May 23, 1997
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985